Total Payments
$26,334
2024 Payments
$639.07
Companies
46
Transactions
633
Medicare Patients
6,006
Medicare Billing
$312,961
Payment Breakdown by Category
Food & Beverage$15,318 (58.2%)
Other$10,235 (38.9%)
Consulting$501.00 (1.9%)
Education$280.38 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,318 | 614 | 58.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,235 | 5 | 38.9% |
| Consulting Fee | $501.00 | 2 | 1.9% |
| Education | $280.38 | 12 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11,576 | 35 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $2,017 | 102 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,569 | 56 | $0 (2022) |
| Boston Scientific Corporation | $1,518 | 75 | $0 (2024) |
| PFIZER INC. | $1,392 | 57 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $901.69 | 30 | $0 (2023) |
| Gilead Sciences, Inc. | $817.21 | 48 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $725.34 | 36 | $0 (2024) |
| Abbott Laboratories | $713.95 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $668.40 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $639.07 | 26 | E.R. Squibb & Sons, L.L.C. ($152.38) |
| 2023 | $947.89 | 21 | AstraZeneca Pharmaceuticals LP ($167.98) |
| 2022 | $1,348 | 35 | Amgen Inc. ($258.48) |
| 2021 | $1,176 | 56 | Siemens Medical Solutions USA, Inc. ($206.75) |
| 2020 | $1,611 | 81 | PFIZER INC. ($364.05) |
| 2019 | $3,217 | 136 | Janssen Pharmaceuticals, Inc ($622.15) |
| 2018 | $6,499 | 138 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,289) |
| 2017 | $10,896 | 140 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,032) |
All Payment Transactions
633 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Obesity | ||||||
| 11/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $31.12 | General |
| 10/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: ACCOLADE_CRM | ||||||
| 09/11/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/06/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: LUX-Dx_CRM | ||||||
| 08/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/20/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Obesity | ||||||
| 07/24/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: LUX-Dx_CRM | ||||||
| 07/08/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.16 | General |
| Category: Cardiovascular | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $124.81 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Cardiovascular | ||||||
| 05/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $0.12 | General |
| Category: Cardiovascular | ||||||
| 04/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/22/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $58.19 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/17/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: LUX-Dx_CRM | ||||||
| 03/12/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $44.02 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/07/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: LUX-Dx_CRM | ||||||
| 02/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,173 | 1,426 | $281,515 | $61,170 |
| 2022 | 21 | 1,630 | 2,083 | $315,479 | $74,839 |
| 2021 | 21 | 1,542 | 1,959 | $339,892 | $77,384 |
| 2020 | 23 | 1,661 | 2,156 | $265,424 | $99,568 |
Total Patients
6,006
Total Services
7,624
Medicare Billing
$312,961
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 104 | $32,136 | $9,218 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 115 | $36,110 | $9,059 | 25.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 17 | 20 | $34,940 | $8,311 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 125 | 126 | $26,208 | $5,778 | 22.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 45 | $27,090 | $5,456 | 20.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 29 | 30 | $38,010 | $4,534 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 77 | $16,247 | $4,348 | 26.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 57 | 58 | $13,688 | $3,327 | 24.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 169 | 204 | $14,688 | $1,890 | 12.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 34 | 84 | $7,560 | $1,566 | 20.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 44 | 113 | $8,249 | $1,564 | 19.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 263 | 282 | $7,332 | $1,485 | 20.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 14 | $4,522 | $1,155 | 25.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $4,494 | $1,058 | 23.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 13 | 16 | $3,680 | $864.77 | 23.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 46 | 47 | $3,055 | $737.12 | 24.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 61 | 62 | $2,666 | $651.48 | 24.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 15 | 15 | $840.00 | $170.11 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 140 | $43,960 | $11,704 | 26.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 137 | $42,333 | $10,655 | 25.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 63 | $37,926 | $8,744 | 23.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 170 | 170 | $35,360 | $8,401 | 23.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 33 | 34 | $29,716 | $6,874 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 95 | $20,045 | $5,559 | 27.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 507 | 592 | $15,392 | $3,374 | 21.9% |
About Dr. David Burkey, MD
Dr. David Burkey, MD is a Cardiovascular Disease healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669432886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Burkey, MD has received a total of $26,334 in payments from pharmaceutical and medical device companies, with $639.07 received in 2024. These payments were reported across 633 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($15,318).
As a Medicare-enrolled provider, Burkey has provided services to 6,006 Medicare beneficiaries, totaling 7,624 services with total Medicare billing of $312,961. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Pittsburgh, PA
- Active Since 03/23/2006
- Last Updated 02/16/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669432886
Products in Payments
- PRADAXA (Drug) $11,274
- ENTRESTO (Drug) $1,939
- XARELTO (Drug) $1,569
- ELIQUIS (Drug) $1,150
- LifeVest (Device) $901.69
- FARXIGA (Drug) $432.90
- Ranexa (Drug) $407.29
- CHANTIX (Drug) $399.92
- Repatha (Biological) $341.02
- COMET (Device) $322.15
- BRILINTA (Drug) $302.60
- JARDIANCE (Drug) $301.87
- PRALUENT ALIROCUMAB INJECTION (Biological) $270.85
- CorPath Imaging System (Device) $226.11
- Corlanor (Drug) $226.03
- VYNDAQEL (Drug) $202.84
- EMBLEM (Device) $199.07
- PRALUENT (Drug) $187.62
- Barostim Neo System (Device) $162.14
- Confirm Rx (Device) $159.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pittsburgh
Dr. John Chenarides, Md, MD
Cardiovascular Disease — Payments: $1.0M
Cardiovascular Disease $1.0M
Dr. George Gabriel, Do, DO
Cardiovascular Disease — Payments: $801,111
Cardiovascular Disease $801,111
Andrew Pogozelski, M.d, M.D
Cardiovascular Disease — Payments: $442,274
Cardiovascular Disease $442,274
Mark Greathouse, Md, MD
Cardiovascular Disease — Payments: $382,075
Cardiovascular Disease $382,075
Ramzi Khalil, Md, MD
Cardiovascular Disease — Payments: $281,654
Cardiovascular Disease $281,654
David Lasorda, Do, DO
Cardiovascular Disease — Payments: $278,090
Cardiovascular Disease $278,090